On the use of fluorescence probes for detecting reactive oxygen and nitrogen species associated with photodynamic therapy

Journal of Biomedical Optics

Volumn 15, Issue 5, 2010, Pages

  Price, Michael ^a   Kessel, David ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fluorescent probes; Photodynamic; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

CELL-FREE SYSTEM; DEGREE OF SPECIFICITY; DICHLOROFLUORESCEIN; FLUORESCENCE PROBES; FLUORESCENT PROBES; FLUOROGENICS; PEROXIDASE ACTIVITIES; PHOTODYNAMIC; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN AND NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; REACTIVE SPECIES;

FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; NITROGEN; OXYGEN; PHOTODYNAMIC THERAPY; TISSUE;

PROBES;

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; 2',7'-DICHLOROFLUORESCEIN; AMINOPHENYL FLUORESCEIN; ANILINE DERIVATIVE; DICHLOROFLUORESCEIN; DIHYDROETHIDINE; DRUG DERIVATIVE; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RHODAMINE;

ANIMAL; ARTICLE; CELL FREE SYSTEM; EVALUATION; FLUORESCENCE MICROSCOPY; LEUKEMIA P 388; METABOLISM; MOUSE; PHASE CONTRAST MICROSCOPY; PHOTOCHEMOTHERAPY; TUMOR CELL LINE;

ANILINE COMPOUNDS; ANIMALS; CELL LINE, TUMOR; CELL-FREE SYSTEM; DICARBETHOXYDIHYDROCOLLIDINE; FLUORESCEINS; FLUORESCENT DYES; LEUKEMIA P388; MICE; MICROSCOPY, FLUORESCENCE; MICROSCOPY, PHASE-CONTRAST; PHOTOCHEMOTHERAPY; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RHODAMINES;

EID: 79952524200     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3484258     Document Type: Article

References (39)

1. Z. Kirkali, T. Chan, M. Manoharan, F. Algaba, C. Busch, L. Cheng, L. Kiemeney, M. Kriegmair, R. Montironi, W. M. Murphy, I. A. Sesterhenn, M. Tachibana, and J. Weider, "Bladder cancer: epidemiology, staging and grading, and diagnosis," Urology 66(6 Suppl. 1), 4-34 (2005).
2. W. Oosterlinck, A. V. Bono, D. Mack, R. Hall, R. Sylvester, C. De Balincourt, and M. Brausi, "Frequency of positive biopsies after visual disappearance of superficial bladder cancer marker lesions," Eur. Urol. 40(5), 515-517 (2001).
3. M. J. Droller, "Biological considerations in the assessment of urothelial cancer: a retrospective," Urology 66(5 Suppl.), 66-75 (2005).
4. D. Jocham, F. Witjes, S. Wagner, B. Zeylemaker, J. Van Moorselaar, M. O. Grimm, R. Muschter, G. Popken, F. König, R. Knüchel, and K. H. Kurth, "Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study," J. Urol. 174(3), 862-866 (2005).
5. J. C. Kennedy, R. H. Pottier, and D. C. Pross, "Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience," J. Photochem. Photobiol., B 6(1-2), 143-148 (1990).
6. J. C. Kennedy and R. H. Pottier, "Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy," J. Photochem. Photobiol., B 14(4), 275-292 (1992).
7. P. Uehlinger, M. Zellweger, G. Wagnieres, L. Juillerat-Jeanneret, H. van den Bergh, and N. Lange, "5-aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells," J. Photochem. Photobiol., B 54(1), 72-80 (2000).
8. P. Jichlinski and D. Jacqmin, "Photodynamic diagnosis in non-muscle-invasive bladder cancer," Eur. Urol. Suppl. 7(7), 529-535 (2008).
9. P. Jichlinski, H. J. Leisinger, L. Guillou, N. Lange, H. Van den Bergh, S. J. Karlsen, B. Brennhovd, P. U. Malmström, E. Johansson, D. Jocham, and T. Gärtner, "Hexyl aminolevulinate fluorescence cystoscopy: a new diagnostic tool for the photodiagnosis of superficial bladder cancer - a multicenter study," J. Urol. 170(1), 226-229 (2003).
10. J. Schmidbauer, F. Witjes, N. Schmeller, R. Donat, M. Susani, and M. Marberger, "Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy," J. Urol. 171(1), 135-138 (2004).
11. H. B. Grossman, L. Gomella, Y. Fradet, A. Morales, J. Presti, C. Ritenour, U. Nseyo, and M. J. Droller, "A phase III, multicenter comparison of hexaminolevulinate fluorescence crystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer," J. Urol. 178(1), 62-67 (2007).
12. Y. Fradet, H. B. Grossman, L. Gomella, S. Lerner, M. Cookson, D. Albala, M. J. Droller, and P. B. S. Group, "A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study," J. Urol. 178(1), 68-73, discussion 73 (2007).
13. D. I. Daniltchenko, C. R. Riedl, M. D. Sachs, F. Koenig, K. L. Daha, H. Pflueger, S. A. Loening, and D. Schnorr, "Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study," J. Urol. 174(6), 2129-2133, discussion 2133 (2005).
14. J. A. Witjes and J. Douglass, "The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer," Nat. Clin. Pract. Urol. 4(10), 542-549 (2007).
15. S. Denzinger, M. Burger, B. Walter, R. Knuechel, W. Roessler, W F Wieland, and T. Filbeck, "Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study," Urology 69(4), 675-679 (2007).
16. M. Babjuk, V. Soukup, R. Petrik, M. Jirsa, and J. Dvoracek, "5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer," BJU Int. 96(6), 798-802 (2005).
17. A. P. M. van Der Meijden, R. Sylvester, W. Oosterlinck, E. Solsona, A. Boehle, B. Lobel, and E. Rintala, "EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ," Eur. Urol. 48(3), 363-371 (2005).
18. P. J. S. Charlesworth and A. L. Harris, "Mechanisms of disease: angiogenesis in urologic malignancies," Nat. Clin. Pract. Urol. 3(3), 157-169 (2006).
19. F. Reiher, O. Ozer, M. Pins, B. D. Jovanovic, S. Eggener, and S. C. Campbell, "p53 and microvessel density in primary resection specimens of superficial bladder cancer," J. Urol. 167(3), 1469-1474 (2002).
20. J. E. East, N. Suzuki, P. Bassett, M. Stavrinidis, H. J. Thomas, T. Guenther, P. P. Tekkis, and B. P. Saunders, "Narrow band imaging with magnification for the characterization of small and diminutive colonic polyps: pit pattern and vascular pattern intensity," Endoscopy 40(10), 811-817 (2008).
21. Y. Kumagai, M. Iida, and S. Yamazaki, "Magnifying endoscopic observation of the upper gastrointestinal tract," Digest. Endosc. 18(3), 165-172 (2006).
22. K. Shibuya, H. Hoshino, M. Chiyo, A. Iyoda, S. Yoshida, Y. Sekine, T. Iizasa, Y. Saitoh, M. Baba, K. Hiroshima, H. Ohwada, and T. Fujisawa, "High magnification bronchovideoscopy combined with narrow band imaging could detect capillary loops of angiogenic squamous dysplasia in heavy smokers at high risk for lung cancer," Thorax 58(11), 989-995 (2003).
23. K. Shibuya, H. Hoshino, M. Chiyo, K. Yasufuku, T. Iizasa, Y. Saitoh, M. Baba, K. Hiroshima, H. Ohwada, and T. Fujisawa, "Subepithelial vascular patterns in bronchial dysplasias using a high magnification bronchovideoscope, " Thorax 57(10), 902-907 (2002).
24. H. Inoue, T. Honda, K. Nagai, T. Kawano, K. Yoshino, K. Takeshita, and M. Endo, "Ultra-high magnification endoscopic observation of carcinoma in situ of the esophagus," Digest. Endosc. 9(1), 16-18 (1997).
25. F. K. Mostofi, L. H. Sobin, and H. Torloni, "Histological typing of urinary bladder tumors," International Histological Classification of Tumors, No. 10, WHO, Geneva (1973).
26. J. I. Epstein, M. B. Amin, V. R. Reuter, F K. Mostofi, F. Algaba, W C. Allsbrook, A. G. Ayala, M. J. Becich, A. L. Beltran, L. Boccon-Gibod, D. G. Bostwick, C. Busch, C. J. Davis, J. N. Eble, C. S. Foster, M. Furusato, D. J. Grignon, P. A. Humphrey, E. A. Ishak, S. L. Johansson, E. C. Jones, L. G. Koss, H. S. Levin, W M. Murphy, R. O. Petersen, A. Renshaw, J. Y. Ro, J. R. Ross, I. A. Sesterhenn, J. R. Srigley, S. Suzigan, J. B. Tomaszewski, P. Troncoso, L. D. True, M. A. Weiss, T. M. Wheeler, and R. H. Young, "The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder," Am. J. Surg. Pathol. 22(12), 1435-1448 (1998).
27. M. C. Hall, S. S. Chang, G. Dalbagni, R. S. Pruthi, J. D. Seigne, E. C. Skinner, J. S. Wolf Jr., and P. F Schellhammer, "Guideline for the management of nonmuscle-invasive bladder cancer (stages Ta, Tl, and Tis): 2007 update," J. Urol. 178(6), 2314-2330 (2007).
28. M. C. Grimbergen, C. F. van Swol, T. G. Jonges, T. A. Boon, and R. J. van Moorselaar, "Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy," Eur. Urol. 44(1), 51-56 (2003).
29. P. Jichlinski, M. Forrer, J. Mizeret, T. Glanzmann, D. Braichotte, G. Wagnières, G. Zimmer, L. Guillou, F Schmidlin, P. Graber, H. D. Van Bergh, and H. J. Leisinger, "Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid: preliminary results," Lasers Surg. Med. 20(4), 402-408 (1997).
30. D. Zaak, W. F Wieland, C. G. Stief, and M. Burger, "Routine use of photodynamic diagnosis of bladder cancer: practical and economic issues," Eur. Urol. Suppl. 7(7), 536-541 (2008).
31. R. O. Draga, M. C. Grimbergen, E. T. Kok, T. N. Jonges, C. F van Swol, and J. L. Bosch, "Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus calmette-guerin immunotherapy and mitomycin c intravesical therapy," Eur. Urol. 57(4), 655-660 (2010).
32. R. O. Draga, M. C. Grimbergen, E. T. Kok, T. N. Jonges, and J. L. Bosch, "Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: identification of patient groups that may benefit most from highly specific optical diagnostics," Urology 74(4), 851-856 (2009).
33. T. D. Wang, S. Friedland, P. Sahbaie, R. Soetikno, P. L. Hsiung, J. T. Liu, J. M. Crawford, and C. H. Contag, "Functional imaging of colonic mucosa with a fibered confocal microscope for real-time in vivo pathology [see comment]," Clin. Gastroenterol. Hepatol. 5(11), 1300-1305 (2007).
34. G. A. Sonn, S. N. Jones, T. V. Tarin, C. B. Du, K. E. Mach, K. C. Jensen, and J. C. Liao, "Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy," J. Urol. 182(4), 1299-1305 (2009).
35. A. Romanenko, K. Morimura, H. Wanibuchi, M. Wei, W Zaparin, W Vinnichenko, A. Kinoshita, A. Vozianov, and S. Fukushima, "Urinary bladder lesions induced by persistent chronic low-dose ionizing radiation," Cancer Sci. 94(4), 328-333 (2003).
36. P. Nowak-Sliwinska, J.-P. Ballini, G. Wagnières, and H. van den Bergh, "Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model," Microvasc. Res. 79(1), 21-28 (2010).
37. M. B. Vickerman, P. A. Keith, T. L. McKay, D. J. Gedeon, M. Watanabe, M. Montano, G. Karunamuni, P. K. Kaiser, J. E. Sears, Q. Ebrahem, D. Ribita, A. G. Hylton, and P. Parsons-Wingerter, "VES-GEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks," Anat. Rec. 292(3), 320-332 (2009).
38. H. W Herr and S. M. Donat, "A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences," BJU Int. 102(9), 1111-1114 (2008).
39. R. Bhuvaneswari, P. S. Thong, Y. Y. Gan, K. Soo, and M. Olivo, "Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy," J. Biomed. Opt. 15(1), 011114 (2010).